WinstonWınston
Back
Revvity logo

Revvity

RVTY
49
Medical - Diagnostics & Research · Healthcare
Also trades as: 0KHE.L
Price
$124.75
+0.62 (+0.50%)
Market Cap
$13.92B
Winston Score
49
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jul 5, 2026
How the score breaks down
Quality
Good
Growth
Mixed
Cash Flow
Exceptional
Stability
Good
Valuation
Good
Dividends
Weak
Track this stock — start free trial

Share count falling — buybacks

−3.0% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 116.7M (2021) → 113.2M (2025)

Winston Score History

The full picture

Revvity makes tools and software that scientists use to study diseases, develop new drugs, and test patients for health conditions. Its products include lab instruments, chemical reagents, and diagnostic tests, sold mainly to hospitals, pharmaceutical companies, and research labs. The company is especially known for newborn screening — its tests help detect rare diseases in babies shortly after birth, and it serves customers in over 190 countries.

Revvity earns money by selling instruments upfront and then generating recurring revenue from consumables, software subscriptions, and services that customers need to keep using those instruments. It operates globally, with significant revenue from North America, Europe, and Asia, and generates roughly $2.8 billion in annual revenue. Its large installed base of instruments creates a natural lock-in, since customers tend to keep buying Revvity's consumables once they own its equipment — but slow growth in pharmaceutical research spending remains a key risk to watch.

Politician Trades

11 trades / 12mo

9 Congressional buys and 2 sells on RVTY in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+1.3% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+0.0% YoY

YoY Growth Rate

Slow EPS growth

R&D Spend

$216M/ year

↑ Rising (+10% vs prior year)

7.6% of revenue

Below sector average (18%)

R&D investment increasing — building for the future

Insider Activity

8.4%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$1.0B cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Revvity is growing revenue at 1% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
57.1%
Premium pricing power — 57.1% gross margin
Profit after running costs
Operating Margin
12.2%
Healthy — 12.2% operating margin
Return on the money invested
ROCE
3.4%
Weak — 3.4% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+4.1%
Slow sales growth (+4.1% YoY)
Profit growth
EPS YoY
-11.0%
Earnings shrinking (-11.0% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
265%
Turns 265% of profit into real cash
Spare cash per sale
FCF Margin
19.2%
Converts sales into free cash efficiently (19.2%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.44
Conservative — low debt load (0.44)
Covers its interest
Interest Cover
3.82x
Tight — interest eats into profit (3.8x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
59.4x
Expensive — P/E 59.4

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+41.5
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (59.4 → 17.9)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
0.24%
Small dividend — 0.24% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+0.0%
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial